Dopaminergic Modulation of Cortical Plasticity in Alzheimer's Disease Patients

Neuropsychopharmacology

Volumn 39, Issue 11, 2014, Pages 2654-2661

  Koch, Giacomo ^a,b   Di Lorenzo, Francesco ^a,b   Bonnì, Sonia ^a   Giacobbe, Viola ^a   Bozzali, Marco ^a   Caltagirone, Carlo ^a,b   Martorana, Alessandro ^b  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMIC ACID DERIVATIVE; CHOLINESTERASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; RIVASTIGMINE; ROTIGOTINE; TETRALIN DERIVATIVE; THIOPHENE DERIVATIVE;

AGED; ALZHEIMER DISEASE; CONTROLLED STUDY; DRUG EFFECTS; FEMALE; HUMAN; MALE; MOTOR CORTEX; NERVE CELL PLASTICITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; TRANSCRANIAL MAGNETIC STIMULATION;

AGED; ALZHEIMER DISEASE; CHOLINESTERASE INHIBITORS; DOPAMINE AGONISTS; FEMALE; HUMANS; MALE; MOTOR CORTEX; NEURONAL PLASTICITY; PHENYLCARBAMATES; TETRAHYDRONAPHTHALENES; THIOPHENES; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84930902431     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2014.119     Document Type: Article

References (50)

1. Appollonio I, Leone M, Isella V, Piamarta F, Consoli T, Villa ML et al (2005). The Frontal Assessment Battery (FAB): Normative values in an Italian population sample. Neurol Sci 26: 108-116.
2. Backman L, Nyberg L, Lindenberger U, Li SC, Farde L (2006). The correlative triad among aging, dopamine, and cognition: Current status and future prospects. Neurosci Biobehav Rev 30: 791-807.
3. Baunez C, Robbins TW (1999). Effects of dopamine depletion of the dorsal striatum and further interaction with subthalamic nucleus lesions in an attentional task in the rat. Neuroscience 92: 1343-1356.
4. Boek hoorn K, Terwel D, Biemans B, Borghgraef P, Wiegert O, Ramakers GJ et al (2006). Improved long-term potentiation and memory in young tau-P301L transgenic mice before onset of hyperphosphorylation and tauopathy. J Neur osci 26: 3514-3523.
5. Boussaoud D, Kermadi I (1997). The primate striatum: Neuronal activity in relation to spatial attention versus motor preparation. Eur J Neurosci 9: 2152-2168.
6. Bozz ali M, Padovani A, Caltagirone C, Borroni B (2011). Regional grey matter loss and brain disconnection across Alzheimer disease evolution. Curr Med Chem 18: 2452-2458.
7. Carlesimo GA, Caltagirone C, G ainotti G (1996). The Mental Deterioration Battery: Normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery. Eur Neurol 36: 37 8-384.
8. Cole DM, Beckmann CF, Searle GE, Plisson C, Tziortzi AC, Nichols TE et al (2011). Orbitofrontal connectivity with resting-state networks is associated with midbrain dopamine D3 receptor availability. Cereb Cortex 22: 2784-2793.
9. Cools R, D'Esposito M (2011). Inverted-U-shaped dopamine actions on human working memory and cognitive control. Biol Psychiatry 69: 113-125.
10. Di Lazzaro V Oliviero A Pilato F Saturno E Dileone M Marra C et al 2005 Neurophysiological predictors of long term response to AChE inhibitors in AD patients. J Neurol Neurosurg Psychiatry 76 1064-1069.
11. Di Lazzaro V, Oliviero A, Tonali PA, Marra C, Daniele A, Profice P et al (2002). Non invasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation. Neurology 59: 392-397.
12. Glickstein SB, Desteno DA, Hof PR, Schmauss C (2005). Mice lacking dopamine D2 and D3 receptors exhibit differential activation of prefrontal cortical neurons during tasks requiring attention. Cereb Cortex 15: 1016-1024.
13. Goldsmith SK, Joyce JN (1996). Dopamine D2 receptors are organized in bands in normal human temporal cortex. Neuroscience 74: 435-451.
14. Himeno E, Ohyagi Y, Ma L, Nakamura N, Miyoshi K, Sakae N et al (2011). Apomorphine treatment in Alzheimer mice promoting amyloid-b degradation. Ann Neurol 69: 248-256.
15. Huang YZ, Edw ards MJ, Rounis E, Bhatia KP, Rothwell JC (2005). Theta burst stimulation of the human motor cortex. Neuron 45: 201-206.
16. Huang YZ, Rothwell JC, Lu CS, Chuang WL, Chen RS (2011). Abnormal bidirectional plasticity-like effects in Parkinson's disease. Brain 134: 2312-2320.
17. Joyce JN, Kaeger C, Ryoo H, Goldsmith S (1993). Dopamine D2 receptors in the hippocampus and amygdala in Alzheimer's disease. Neurosci Lett 154: 171-174.
18. Joyce JN, Myers AJ, Gurevich E (1998). Dopamine D2 receptor bands in normal human temporal cortex are absent in Alzheimer's disease. Brain Res 784: 7-17.
19. Kemppainen N, Laine M, Laakso MP, Kaasinen V, Na°gren K, Vahlberg T et al (2003). Hippocampal dopamine D2 receptors correlate with memory functions in Alzheimer's disease. Eur J Neurosci 18: 149-154.
20. Kishore A, Popa T, Velayudhan B, Joseph T, Balachandran A, Meunier S (2012). Acute dopamine boost has a negative effect on plasticity of the primary motor cortex in advanced Parkinson's disease. Brain 135: 2074-2088.
21. Klyubin I, Betts V, Welzel AT, Blennow K, Zetterberg H, Wallin A et al (2008). Amyloid beta protein dimer-containing human CSF disrupts synaptic plasticity: Prevention by systemic passive immunization. J Neurosci 28: 4231-4237.
22. Koch G, Esposito Z, Kusayanagi H, Monteleone F, Codecá C, Di Lorenzo F et al (2011). CSF Tau levels influence cortical plasticity in Alz heimer's disease patients. J Alzheimers Dis 26: 181-186.
23. Koch G, Di Lorenzo F, Bonn? S, Ponzo V, Caltagirone C, Martorana A (2012). Impaired LTP-but not LTD-like cortical plasticity in Alzheimer's disease patients. J Alzheimers Dis 31: 593-599.
24. Kumar U, Patel SC (2007). Immunohistochemical localization of dopamine receptor subtypes (D1R-D5R) in Alzheimer's disease brain. Brain Res 1131: 187-196.
25. Kuo MF, Paulus W, Nitsche MA (2008). Boosting focally-induced brain plasticity by dopamine. Cereb Cortex 18: 648-651.
26. Kurniawan IT, Guitart-Masip M, Dolan RJ (2011). Dopamine and effort-based decision making. Front Neurosci 21: 81.
27. Li S, Hong S, Shepardson NE, Walsh DM, Shankar GM, Selkoe D (2009). Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term dep ression by disrupting neuronal glutamate uptake. Neuron 62: 788-801.
28. Manahan-Vaughan D, Kulla A (2003). Regulation of depotentiation and long-term potentiation in the dentate gyrus of freely moving rats by dopamine D2-like receptors. Cereb Cortex 13: 123-135.
29. Martorana A, Mori F, Esposito Z, Kusayanagi H, Monteleone F, Codecà C et al (2009). Dopamine modulates cholinergic cortical excitability in Alzheimer's disease patients. Neuropsychopharmacology 34: 2323-2328.
30. Martorana A, Esposito Z, Koch G (2010). Beyond the cholinergic hypothesis:do current drugs work in Alzheimer's disease? CNS Neurosci Ther 16: 235-245.
31. Martorana A Di Lorenzo F Esposito Z Lo Giu dice T Bernardi G Caltagirone C et al 2013 Dopamine D2-agonist rotigotine effects on cortical excitability and central cholinergic transmission in Alzheimer's disease patients. Neuropharmacology 64 108-113.
32. Monte-Silva K, Kuo MF, Thirugnanasambandam N, Liebetanz D, Paulus W, Nitsche MA (2009). Dose-dependent inverted U-shaped effect of dopamine (D2-like) receptor activation on focal andnonfocal plasticity in humans. J Neurosci 29: 6124-6131.
33. Monte-Silva K, Ruge D, Teo JT, Paulus W, Rothwell JC, Nitsche MA (2011). D2 receptor block abolishes y burst stimulationinduced neuroplasticity in the human motor cortex. Neu ropsychopharmacology 36: 2097-2102.
34. Nitsche MA, Kuo MF, Grosch J, Bergner C, Monte-Silva K, Paulus W (2009). D1-receptor impact on neuroplasticity in humans. J Neurosci 29: 2648-2653.
35. Otmakhova NA, Lisman JE (1998). D1/D5 dopamine receptors inhibit depotentiation at CA1 synapses via cAMP-dependent mechanism. J Neurosci 18: 1270-1279.
36. Palop JJ, Mucke L (2010). Amylo id-beta-induced neuronal dysfunction in Alzheimer's disease: From synapses toward neural networks. Nat Neurosci 13: 812-818.
37. Paspalas CD, Goldman-Rakic PS (2005). Presynaptic D1 dopamine receptors in primate prefrontal cortex: Target-specific expression in the glutamatergic synapse. J Neurosci 25: 1260-1267.
38. Pizzolato G, Chierichetti F, Fabbri M, Cagnin A, Dam M, Ferlin G et al (1998). Reduced str iatal dopamine receptors in Alzheimer's disease: Single photon emission tomography study with the D2 tracer [123I]-IBZM. Neurology 47: 1065-1068.
39. Rajji TK, Sun Y, Zomorrodi-Moghaddam R, Farzan F, Blumberger DM, Mulsant BH et al (2013). PAS-induced potentiation of cortical-evoked activity in the dorsolateral prefrontal cortex. Neuropsychopharmacol 38: 2545-2552.
40. Rossini PM, Barker AT, Berardelli A, Cara mia MD, Caruso G, Cracco RQ et al (1994). Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: Basic principles and procedures for routine clinical application. Report of an IFCN committee. Elect roencephalogr Clin Neurophysiol 91: 79-92.
41. Ryoo HL, Joyce JN (1994). Loss of dopamine D2 receptors varies along the rostrocaudal axis of the hippocampal complex in Alzheimer's disease. J Comp Neurol 348: 94-110.
42. Sailer A, Molnar GF, Paradiso G, Gunraj CA, Lang AE, Chen R (2003). Short and long latency afferent inhibition in Parkinson's disease. Brain 126: 1883-1894.
43. Seamans JK, Yang CR (2004). The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol 74: 1-58.
44. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, S hepardson NE, Smith I et al (2008). Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14: 837-842.
45. Suvà D, Favre I, Kraftsik R, Esteban M, Lob rinus A, Miklossy J (1999). Primary motor cortex involvement in Alzheimer disease. J Neuropathol Exp Neurol 58: 1125-1134.
46. Tanaka Y, Meguro K, Yamaguchi S, Ishii H, Watanuki S, Funaki Y et al (2003). Decreased striatal D2 receptor density associated with severe behavioral abnormality in Alzheimer's disease. Ann Nucl Med 17: 567-573.
47. Tritsch NX, Sabatini BL (2012). Dopaminergic modulation of synaptic transmission in cortex and striatum. Neuron 76: 33-50.
48. Varma AR, Snowden JS, Lloyd JJ, Talbot PR, M ann DM, Neary D. (1999). Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry 66: 184-188.
49. Veniero D, Ponzo V, Koch G (2013). Paired associative stimulation enforces the communication between interconnected areas. J Neurosci 33: 13773-13783.
50. Zhang L, Doyon WM, Clark JJ, Phillips PE, Dani JA (2009). Controls of tonic and phasic dopamine transmission in the dorsal and ventral striatum. Mol Pharmacol 76: 396-404.